National Key Research and Development Program of China
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial
Jia Liao, Gang Zhao, Gregg W. Stone, Xiaoping Peng et al.
Citations
2 citations
Journal
BMC Medicine
Topics
Heparin-Induced Thrombocytopenia and Thrombosis
Field-Weighted Citation Impact (FWCI)
1.15
article
Bivalirudin versus heparin in patients with or without bail-out GPI use: a pre-specified subgroup analysis from the BRIGHT-4 trial
Jia Liao, Gang Zhao, Gregg W. Stone, Xiaoping Peng, Nai‐Liang Tian, Zeqi Zheng, Dingbao Zhang, Miaohan Qiu, Yaling Han, Kui Chen, Yi Li, Xiaojian Feng, Qing Yang, Zhenyang Liang, Yuncheng Zou, Xiaohui Zheng
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMC MedicineVol. 22(1)
Institutions
Union Hospital (HK), Nanchang University (CN), Cardiovascular Institute of the South (US), Tianjin Medical University General Hospital (CN), Northern Hospital (AU), Second People's Hospital of Yunnan Province (CN), Shanghai University of Traditional Chinese Medicine (CN), Mount Sinai Hospital (US), Shanghai Liangyou (China) (CN), General Hospital of Shenyang Military Region (CN), Yueyang Second People's Hospital (CN), Yueyang Hospital (CN), Zhengzhou Central Hospital (CN), First Affiliated Hospital of Zhengzhou University (CN), Pingliang People's Hospital (CN), First Affiliated Hospital of Nanchang University (CN), Huazhong University of Science and Technology (CN), Nanjing Medical University (CN)
Funders
National Key Research and Development Program of China